Merit Medical Systems, Inc. (MMSI)
| Market Cap | 5.19B -2.1% |
| Revenue (ttm) | 1.61B +9.1% |
| Net Income | 160.12M +35.2% |
| EPS | 2.67 +36.9% |
| Shares Out | 59.92M |
| PE Ratio | 32.43 |
| Forward PE | 19.28 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 421,764 |
| Open | 86.95 |
| Previous Close | 86.69 |
| Day's Range | 85.97 - 87.37 |
| 52-Week Range | 59.74 - 94.85 |
| Beta | 0.55 |
| Analysts | Buy |
| Price Target | 107.00 (+23.51%) |
| Earnings Date | Oct 29, 2026 |
About MMSI
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology produc... [Read more]
Financial Performance
In 2025, Merit Medical Systems's revenue was $1.52 billion, an increase of 11.75% compared to the previous year's $1.36 billion. Earnings were $128.49 million, an increase of 6.76%.
Financial StatementsAnalyst Summary
According to 12 analysts, the average rating for MMSI stock is "Buy." The 12-month stock price target is $107.0, which is an increase of 23.51% from the latest price.
News
Merit Medical Presents Real-World Data from the AVF Cohort of the WRAP Global Registry
SOUTH JORDAN, Utah, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced results from the AVF cohort of the WRAPSODY ...
Merit Medical price target raised to $116 from $114 at Barrington
Barrington raised the firm’s price target on Merit Medical (MMSI) to $116 from $114 and keeps an Outperform rating on the shares. The firm views the company’s Q3 report as…
Merit Medical price target raised to $110 from $95 at JPMorgan
JPMorgan raised the firm’s price target on Merit Medical (MMSI) to $110 from $95 and keeps an Overweight rating on the shares.
Merit Medical price target raised to $106 from $101 at Needham
Needham raised the firm’s price target on Merit Medical (MMSI) to $106 from $101 and keeps a Buy rating on the shares. The company’s Q3 earnings topped estimates as operating…
Merit Medical price target raised to $110 from $105 at BTIG
BTIG analyst Sam Eiber raised the firm’s price target on Merit Medical (MMSI) to $110 from $105 and keeps a Buy rating on the shares. The company delivered another broad-based…
Merit Medical price target raised to $121 from $94 at Canaccord
Canaccord raised the firm’s price target on Merit Medical (MMSI) to $121 from $94 and keeps a Buy rating on the shares. The firm said they reported a clean beat-and-raise…
Merit Medical price target raised to $107 from $100 at Baird
Baird analyst David Rescott raised the firm’s price target on Merit Medical (MMSI) to $107 from $100 and keeps an Outperform rating on the shares.
Merit Medical Systems Earnings Call Transcript: Q3 2026
Q3 revenue rose 8% and organic constant-currency growth was 9%, while operating margin expanded 160 bps. FY2026 EPS guidance increased, and the $45 million Solo Pace acquisition extends the structural heart portfolio.
Merit Medical Systems Earnings release: Q3 2026
Merit Medical Systems released its Q3 2026 earnings on October 29, 2026, summarizing the period's financial results.
Merit Medical Systems Quarterly report: Q3 2026
Merit Medical Systems has published its Q3 2026 quarterly earnings report on October 29, 2026.
Merit Medical Systems Slides: Q3 2026
Merit Medical Systems has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on October 29, 2026.
Merit Medical acquires Solo Pace for $45M
Merit Medical (MMSI) Systems announced its acquisition of Solo Pace. Located in Minneapolis, Minnesota, Solo Pace manufactures temporary pacing technology designed to help physicians treat patients wi...
Merit Medical Reports Third Quarter 2026 Results: Delivers 9% Organic Constant Currency Revenue Growth and Raises Full-Year 2026 Guidance
Financial Highlights† Reported revenue of $416.2 million, up 8.4% Constant currency revenue* and constant currency revenue, organic* up 8% and up 9%, respectively GAAP operating margin of 14.1%, compa...
Merit Medical Acquires Solo Pace, Inc., Expanding Its Cardiac Therapies Platform with Innovative TAVR Pacing Technology
SOUTH JORDAN, Utah, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced its acquisition of Solo Pace, Inc. (Solo Pac...
Merit Medical initiated with a Hold at Freedom Capital
Freedom Capital initiated coverage of Merit Medical (MMSI) with a Hold rating and $90 price target The shares trade at a valuation in-line with the peer group median despite modestly…
Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026
SOUTH JORDAN, Utah, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results f...
Merit Medical Systems Transcript: Wells Fargo 21st Annual Healthcare Conference
The team reported ~9% Q2 growth and reaffirmed 2026 guidance, while completing a global platform review for a new long-range plan expected by February at the latest. Management highlighted OneMark market expansion, European embolic momentum, and plans to lean into China.
Merit Medical to Participate in Upcoming Investors Conferences in September
SOUTH JORDAN, Utah, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management is scheduled to participate...
Merit Medical Announces Global Operations Leadership Transition
SOUTH JORDAN, Utah, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer of healthcare technology, today announced that Sheri Lewis has agreed to...
Merit Medical price target raised to $97 from $92 at BofA
BofA raised the firm’s price target on Merit Medical (MMSI) to $97 from $92 and keeps a Neutral rating on the shares after hosting CFO Raul Parra for a virtual…
Merit Medical Systems Transcript: Bank of America SMID Cap Virtual Conference
The event highlighted ongoing strategic planning, a new reporting structure, and strong financial performance, including margin expansion and raised revenue guidance. Growth is driven by both Foundational and Therapeutic platforms, with disciplined M&A and a focus on deepening existing market presence.
Merit Medical Systems Transcript: Canaccord Genuity's 46th Annual Growth Conference
The company is on track to meet its current strategic goals and is developing a new three-year plan, with a focus on portfolio optimization, operational efficiency, and targeted M&A. Recent product launches and acquisitions are expanding market reach, while leadership emphasizes execution and adaptability.
Merit Medical to Participate in Upcoming Investors Conferences in August
SOUTH JORDAN, Utah, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management will participate in the upco...
Merit Medical price target raised to $94 from $85 at Canaccord
Canaccord raised the firm’s price target on Merit Medical (MMSI) to $94 from $85 and keeps a Buy rating on the shares. The firm said they reported an all-around, strong…
Merit Medical price target raised to $114 from $107 at Barrington
Barrington analyst Michael Petusky raised the firm’s price target on Merit Medical (MMSI) to $114 from $107 and keeps an Outperform rating on the shares. The firm views the company’s…